The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 10, 2024
Filed:
Mar. 26, 2021
Applicant:
Twi Biotechnology, Inc., Taipei, TW;
Inventors:
Chih-Ming Chen, Taipei, TW;
Guang-Wei Lu, Irvine, CA (US);
Ling-Ying Liaw, Taipei, TW;
Fan-Lun Liu, Taipei, TW;
Shih-Fen Liao, Taipei, TW;
Chou-Hsiung Chen, Taipei, TW;
Yu-Han Kao, Taipei, TW;
Yu-Yin Chen, Taipei, TW;
Assignee:
TWI BIOTECHNOLOGY, INC., Taipei, TW;
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/519 (2006.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 9/08 (2006.01); A61K 47/10 (2017.01); A61K 47/20 (2006.01); A61K 47/38 (2006.01); A61P 17/06 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0014 (2013.01); A61K 9/06 (2013.01); A61K 9/08 (2013.01); A61K 31/519 (2013.01); A61K 47/10 (2013.01); A61K 47/20 (2013.01); A61K 47/38 (2013.01); A61P 17/06 (2018.01);
Abstract
A topical formulation comprising (a) a therapeutically effective amount of tofacitinib; (b) at least one solvent; and (c) optionally one or more other pharmaceutically acceptable excipients is provided. Also provided is a method for treating and/or preventing autoimmune diseases in a subject administering said topical formulation.